Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Glioblastoma 15Gliosarcoma 13Brain Neoplasms 7Astrocytoma 5Glioma 4Central Nervous System Neoplasms 4Oligodendroglioma 3Pinealoma 2Meningioma 2Medulloblastoma 2Untreated Childhood Medulloblastoma 1Squamous Cell Carcinoma of Head and Neck 1Salivary Gland Neoplasms 1Optic Nerve Glioma 1Neurotoxicity Syndromes 1Neuroma, Acoustic 1Neuroectodermal Tumors, Primitive 1Neuroblastoma 1Head and Neck Neoplasms 1Glioma, Subependymal 1Ganglioneuroblastoma 1Esthesioneuroblastoma, Olfactory 1Ependymoma 1Diffuse Intrinsic Pontine Glioma 1Craniopharyngioma 1Choroid Plexus Neoplasms 1Central Nervous System Nongerminomatous Germ Cell Tumor 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Temozolomide 15Radiotherapy 11Everolimus 6Bevacizumab 6Irinotecan 5Cyclophosphamide 5ribociclib 4Radiation 4Panobinostat 4TIC10 compound 3Specimen Handling 3Re-Irradiation 3Etoposide 3Dasatinib 3pembrolizumab 2nimotuzumab 2abemaciclib 2Vorinostat 2Valproic Acid 2Topotecan 2Nivolumab 2Mebendazole 2Magnetic Resonance Spectroscopy 2Granulocyte-Macrophage Colony-Stimulating Factor 2Gemcitabine 2GDC-0084 2Erlotinib Hydrochloride 2Diphtheria-Tetanus Vaccine 2Cilengitide 2Cetuximab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Diffuse Intrinsic Pontine Glioma × Radiotherapy, Conformal × CNS × Clear all
NCT01189266 2021-10-28

Vorinostat and Radiation Therapy Followed by Maintenance Therapy With Vorinostat in Treating Younger Patients With Newly Diagnosed Diffuse Intrinsic Pontine Glioma

National Cancer Institute (NCI)

Phase 1/2 Completed
79 enrolled 17 charts
CNSSarcoma

Diffuse Intrinsic Pontine Glioma, Astrocytoma, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡